Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any immunodeficiency disease which the cause of the disease is a mutation in the PTPRC gene.
Features include always present findings: Decreased total T cell count, Decreased circulating total IgM, Decreased circulating immunoglobulin concentration, and Absence of lymph node germinal center and others. 16 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 2 | B-cell lymphoma, Low blood cell counts (all types) (pancytopenia) |
PTPRC function has not been fully characterized.
Immunodeficiency 105 is associated with mutations in the PTPRC gene on chromosome 1.
Genetic testing for PTPRC is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for immunodeficiency 105 has been reported in the published literature.
Phenotype severity distribution: 15 always present features.
No clinical trials have been registered for immunodeficiency 105.
228 publications have been identified in PubMed for immunodeficiency 105. Research spans Epidemiology / Natural History (43%), Clinical Trial Publication (14%), and Review / Meta-Analysis (12%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 99 | 43% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:42 AM UTC
Online Mendelian Inheritance in Man
Metabolism |
1 |
Fever |
Skin | 1 | Skin rash |
Digestive system | 1 | Hepatosplenomegaly |
Age of onset: childhood.
33 |
14% |
Research summaries | 27 | 12% |
Patient case studies | 26 | 11% |
Laboratory research | 26 | 11% |
Testing and diagnosis research | 14 | 6% |
New treatment approaches | 2 | 1% |
Other research | 1 | 0% |
Gou Y (2026). [PMID: 42065201](https://pubmed.ncbi.nlm.nih.gov/42065201/). *Medicine (Baltimore)*. [Epidemiology / Natural History]
Hsu ML (2026). [PMID: 42006281](https://pubmed.ncbi.nlm.nih.gov/42006281/). *JTO Clin Res Rep*. [Epidemiology / Natural History]
Abubakir M (2026). [PMID: 41496009](https://pubmed.ncbi.nlm.nih.gov/41496009/). *Medicine (Baltimore)*. [Case Report / Case Series]
Hampanda K (2026). [PMID: 41781994](https://pubmed.ncbi.nlm.nih.gov/41781994/). *Trials*. [Clinical Trial Publication]
Sakai Y (2026). [PMID: 41824830](https://pubmed.ncbi.nlm.nih.gov/41824830/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Bártová E (2026). [PMID: 42400719](https://pubmed.ncbi.nlm.nih.gov/42400719/). *Acta Parasitol*. [Epidemiology / Natural History]
Sticchi L (2026). [PMID: 41687362](https://pubmed.ncbi.nlm.nih.gov/41687362/). *Vaccine*. [Case Report / Case Series]
He L (2026). [PMID: 42151765](https://pubmed.ncbi.nlm.nih.gov/42151765/). *BMC Bioinformatics*. [Basic Science / Preclinical]
Teutsch S (2026). [PMID: 42475728](https://pubmed.ncbi.nlm.nih.gov/42475728/). *Commun Dis Intell (2018)*. [Epidemiology / Natural History]
Demirtas D (2026). [PMID: 41790642](https://pubmed.ncbi.nlm.nih.gov/41790642/). *Medicine (Baltimore)*. [Epidemiology / Natural History]